For a pharmacist appointment after pharmacogenetic testing, bring the full laboratory report, your current prescriptions and non-prescription products, previous medication history, allergies, relevant diagnoses and laboratory information, and notes about the exact medication question. A colour summary alone is usually less useful than the complete report with genotype, phenotype, interpretation, evidence, and limitations.
Pharmacogenetic testing becomes more practical when the report is connected to a current prescribing or medication-management question. A pharmacist can help review the drug-gene sections alongside interactions, dose, treatment history, and the rest of the medication list.
CPIC guidelines help clinicians understand how available genetic results may be used for specific medications. They do not decide whether a test should be ordered and are not intended for self-directed medication changes.
The complete pharmacist appointment checklist
Full PGx report
Bring every page, including methodology, genotype, phenotype, evidence level, medication tables, report date, and limitations.
Current medication list
Include prescription drugs, over-the-counter products, vitamins, natural health products, and supplements with doses and schedules.
Past medication history
List medicines that did not work as expected, caused difficult side effects, or were stopped, including approximate dates and doses.
Relevant health information
Bring known allergies, diagnoses, recent kidney or liver results when relevant, pregnancy status, and monitoring information.
One primary question
State whether you are reviewing a new prescription, prior side effect, limited benefit, dose question, or medication combination.
Prescriber details
Know which physician or nurse practitioner manages the medication and how follow-up information should be shared.
Which PGx report pages matter most?
- Patient and sample identifiers
- Laboratory name and report date
- Genes and variants included in the panel
- Genotype and predicted phenotype assignments
- Medication-specific recommendations or classifications
- Evidence level and cited guideline source
- Test limitations and variants not assessed
- Any corrected, amended, or updated report notice
How to prepare an accurate medication list
Health Canada advises people to share their medical history and ask healthcare professionals about interactions involving prescription drugs, non-prescription products, foods, beverages, vitamins, and herbal products. A PGx review needs the same broad view.
Use generic and brand names when possible
Different brand names may contain the same active ingredient. Copy the drug identification number, active ingredient, dose, and directions from the label or pharmacy record when available.
Include “as needed” medications
A medicine taken only occasionally can still matter if it inhibits or induces an enzyme or contributes to sedation, bleeding, blood pressure changes, or another treatment concern.
Include supplements and natural health products
Do not assume that a product is irrelevant because it was purchased without a prescription. The pharmacist needs the complete list to check interactions and decide which PGx finding is relevant.
How to describe previous benefit and side effects
Avoid writing only “did not work” or “caused side effects.” Specific details make the review more useful.
| Detail | Useful information | Why it helps |
|---|---|---|
| Medication and dose | Name, strength, schedule, and formulation | Drug-gene guidance can differ by medication and exposure |
| Reason for use | Diagnosis or symptom the medication was intended to treat | The same drug can be used for different clinical goals |
| Time to benefit | When improvement started, if it occurred | Helps distinguish early intolerance from lack of response |
| Side-effect details | What happened, when it began, severity, and whether it resolved | Genetics cannot explain every reaction, so the pattern matters |
| Other changes | New medicine, illness, dose change, smoking change, or supplement | Non-genetic factors can alter the clinical phenotype |
Questions to ask the pharmacist
- Does my current medication have a guideline-supported gene-drug relationship?
- Was the relevant gene and necessary variant type included in this panel?
- Does another medication change the predicted enzyme activity?
- Does the report use current phenotype terminology?
- Is the recommendation relevant to my dose, indication, age, and health status?
- What information should be sent to the prescriber?
- Is additional monitoring or a clinical laboratory test needed?
- Should this report be reviewed again if my medication list changes?
Ask about drug interactions and phenoconversion
A genotype-based phenotype can differ from real-time enzyme activity. Strong enzyme inhibitors, inducers, smoking, inflammation, illness, and other factors may contribute to phenoconversion. CYP2D6 is a commonly discussed example.
This is why the pharmacist needs both the genetic report and the active medication list. The genetic result may be stable while the functional interpretation changes with the treatment environment.
A traffic-light colour is not the final answer
A green, yellow, or red category may simplify a report, but it cannot show every interaction, diagnosis, treatment alternative, or monitoring requirement. Ask the pharmacist to review the detailed evidence behind the colour.
Canadian appointment and access realities
Call before booking
Pharmacogenetic experience varies. Ask whether the pharmacist reviews external PGx reports, whether the appointment is in person or remote, what documents must be submitted in advance, and whether a fee applies.
Scope and reimbursement can vary
Pharmacy services, documentation requirements, public programmes, employer benefits, and private coverage differ across provinces, territories, and plans. Confirm the appointment cost and whether a receipt is available.
Remote communities may need document planning
People in rural, northern, island, or smaller communities may use a telephone or video appointment when an appropriate service is available. Confirm how the report and medication list will be sent securely and how recommendations will reach the prescriber.
Bring the report again during care transitions
A community pharmacy, hospital, specialist office, and provincial record may not automatically share the same external PGx report. Bring the current copy after moving, changing pharmacies, or leaving hospital.
What the pharmacist may review
- Whether the current drug appears in a recognized PGx guideline
- Whether the tested genotype supports the reported phenotype
- Whether interactions may change the functional phenotype
- Whether dose, formulation, or indication affects relevance
- Whether the report is old or incomplete
- Whether another healthcare professional should be involved
- What information should be documented for future medication reviews
What the appointment cannot guarantee
No guaranteed “best” medication
PGx can support comparison for selected gene-drug pairs, but it cannot guarantee benefit or identify a perfect medication.
No zero-risk medication
A favourable PGx category does not eliminate side effects, allergies, interactions, or monitoring needs.
No replacement for diagnosis
The report does not diagnose depression, pain disorders, ADHD, cardiovascular disease, or another condition.
No self-directed dose change
The pharmacist may identify considerations, but medication changes must follow the appropriate prescribing and care process.
Useful internal resources
Sources and editorial basis
- Health Canada. Using medications safely.
- Clinical Pharmacogenetics Implementation Consortium. CPIC guidelines.
- Cicali EJ, et al. How to integrate CYP2D6 phenoconversion into clinical pharmacogenetics.
- Nahid NA, Johnson JA. CYP2D6 pharmacogenetics and phenoconversion in personalized medicine.
Editorial note: This article helps readers prepare for a professional medication discussion. It does not provide a personal prescribing recommendation.
